Skip to main content
Full access
Letters to the Editor
Published Online: 1 July 2020

Comment on Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind

To the Editor: We read with interest the article by Dugré et al. (1), published in the December 2019 issue of the Journal. The authors suggest that amygdala activity in response to “neutral” stimuli is increased in patients with schizophrenia compared with healthy subjects, and they recommend investigation of at-risk individuals to differentiate cause from effects. We believe that their claim overstates the case and that their suggestion for further study has already been investigated.
First, we are concerned that the investigation of amygdala response to “neutral” stimuli is unlikely to be a scientifically appropriate approach. It is well known that the human amygdala may respond to stimuli presented as “neutral” because of their novelty, ambiguity, and uncertain nature (2, 3). Therefore, the concept of a “neutral” stimulus in a constrained, noisy, and unfamiliar environment such as the MRI machine is questionable. This is even more problematic when comparing two populations with very different mental states, particularly when comparing healthy control subjects, who likely include paid volunteers who have been in the MRI machine many times, and patients with schizophrenia, who likely are less exposed to the MRI research environment. We are concerned that the authors’ conclusions oversimplify complex biological and psychological phenomena.
Our second observation pertains to the authors’ recommendations for further study of individuals at risk for psychosis. Although we certainly agree that studying individuals at risk for schizophrenia (i.e., individuals without the confounding factor of the state of illness) is of crucial importance to differentiate cause from effect, it is surprising that the authors failed to mention a substantial contribution to the scientific literature that reported exactly that. Ten years ago, our group published a study in the Journal whose goal was to disentangle this conundrum. We explored the amygdala response to threatening faces in a relatively large sample of healthy siblings of patients with schizophrenia and compared them with a sample of healthy control subjects. We demonstrated that the abnormal reactivity of the amygdala observed in patients with schizophrenia was not observed in their healthy siblings, suggesting that factors other than genes are implicated in the phenomenon in patients (4).
Another method to explore whether amygdala response is mediated by risk for schizophrenia and not the state of having the illness is to investigate association with polygenic risk scores (PRSs). Using the results from the second meta-analysis from the Psychiatric Genomics Consortium (5) for each healthy participant, we generated polygenic risk profile scores for schizophrenia, which are an index of the cumulative genetic risk across the genome, and we explored whether higher PRSs predict greater amygdala reactivity. We have computed multiple schizophrenia PRSs for a sample of healthy control subjects (N=332) using p value thresholds ranging from p<1 (all linkage disequilibrium–independent single-nucleotide polymorphisms [SNPs]) to p<1×10−8 (genome-wide association study–significant SNPs) and weighted by the logarithm of the odds ratio from results of the second meta-analysis by the Psychiatric Genomics Consortium Schizophrenia Working Group, as described previously (5). All participants were right-handed, and there were 195 females and 137 males. The mean age of participants was 29.4 years (SD=8.9). Mean participant IQ, as measured by the Wechsler Adult Intelligence Scale, was 109.7 (SD=9.0). Results of the association between PRSs and amygdala reactivity are presented in Table 1. None of the individuals’ PRSs analyzed were even remotely predictive of individual amygdala reactivity to threatening stimuli. Our new findings confirm our early work in healthy siblings that exaggerated amygdala responsivity is not risk-associated pathophysiology for schizophrenia.
TABLE 1. Polygenic risk scores (PRSs) and amygdala reactivity of participants in a study of the association between PRSs and amygdala reactivitya
PRS GWAS pZ Values +/− CorrelationFWE-Corrected p
1×10–82.05/2.301/1
1×10–61.75/2.651/1
1×10–4Null/1.94Null/1
0.0012.53/2.861/1
0.011.98/1.941/1
0.052.55/2.001/1
0.12.42/2.221/1
0.22.44/1.961/1
0.52.19/1.951/1
1.02.18/1.991/1
a
FWE=family-wise error; GWAS=genome-wide association study.
In summary, we recommend caution in interpretation of data obtained from ambiguous experimental conditions and a more careful evaluation of the results in light of the current scientific literature.

References

1.
Dugré JR, Bitar N, Dumais A, et al: Limbic hyperactivity in response to emotionally neutral stimuli in schizophrenia: a neuroimaging meta-analysis of the hypervigilant mind. Am J Psychiatry 2019; 176:1021–1029
2.
Hariri AR, Tessitore A, Mattay VS, et al: The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002; 17:317–323
3.
Sander D, Grafman J, Zalla T: The human amygdala: an evolved system for relevance detection. Rev Neurosci 2003; 14:303–316
4.
Rasetti R, Mattay VS, Wiedholz LM, et al: Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. Am J Psychiatry 2009; 166:216–225
5.
Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511:421–427

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 639 - 640

History

Accepted: 27 January 2020
Published online: 1 July 2020
Published in print: July 01, 2020

Keywords

  1. Schizophrenia Spectrum and Other Psychotic Disorders
  2. Biological Markers
  3. Brain Imaging Techniques
  4. fMRI
  5. Amygdala
  6. Psychosis
  7. Schizophrenia

Authors

Affiliations

Roberta Rasetti, M.D. [email protected]
Department of Psychiatry, Medstar Georgetown University Hospital, Washington, DC (Rasetti); Lieber Institute for Brain Development and Maltz Research Laboratories, Baltimore (Chen, Weinberger); Department of Neurology, Department of Neuroscience, Department of Psychiatry and Behavioral Sciences, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore (Weinberger).
Qiang Chen, Ph.D.
Department of Psychiatry, Medstar Georgetown University Hospital, Washington, DC (Rasetti); Lieber Institute for Brain Development and Maltz Research Laboratories, Baltimore (Chen, Weinberger); Department of Neurology, Department of Neuroscience, Department of Psychiatry and Behavioral Sciences, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore (Weinberger).
Daniel R. Weinberger, M.D.
Department of Psychiatry, Medstar Georgetown University Hospital, Washington, DC (Rasetti); Lieber Institute for Brain Development and Maltz Research Laboratories, Baltimore (Chen, Weinberger); Department of Neurology, Department of Neuroscience, Department of Psychiatry and Behavioral Sciences, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore (Weinberger).

Notes

Send correspondence to Dr. Rasetti ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share